University of British Columbia
Optimization, validation, and feasibility assessment of the kinetic image cytometer for high-throughput optical mapping of human iPSC-derived cardiomyocytes
Abstract
dc:descriptionCardiotoxicity remains a major barrier in drug development because conventional screening approaches do not fully capture integrated human cardiomyocyte electrophysiology, calcium handling, and drug responsiveness in a scalable format. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide a human-relevant model for functional cardiotoxicity testing, but require optimized culture, staining, stimulation, acquisition, and analysis workflows for high-throughput optical mapping. This thesis evaluated whether the IC200 Kinetic Image Cytometer (KIC) could be optimized as a plate-based optical mapping platform for hiPSC-CM electrophysiological phenotyping and future cardiotoxicity screening. The original goal was to integrate the KIC with the Centre for High-throughput Chemical Biology robotic system to screen more than 50,000 compounds. However, physical space constraints prevented robotic integration. The project was therefore revised to focus on foundational platform optimization. hiPSC-CM culture conditions, Matrigel coating, seeding density, FluoVolt and CalBryte 630 AM staining, electrical stimulation, acquisition settings, and analysis workflows were systematically optimized. The optimized workflow supported interleaved voltage-calcium imaging at 50 frames per second, enabling paired action potential duration (APD) and calcium transient duration (CTD) measurements from the same well. Voltage-only imaging was achieved at 195 frames per second, improving temporal resolution for optical action potential analysis. Pharmacological proof-of- concept experiments demonstrated detection of dofetilide-associated prolongation of late APD and CTD measurements, as well as isoproterenol-associated APD shortening. RPR-260243 produced variable responses, highlighting the importance of endpoint selection, replicate number, and well-level variability. Overall, this thesis demonstrates that the KIC can be optimized for hiPSC-CM optical mapping and drug-response testing but is not yet a turn-key high-throughput screening platform. In this thesis, validation refers to demonstrating that the optimized KIC workflow could generate interpretable voltage and calcium recordings and detect expected directional responses to a limited set of pharmacological interventions under the specific experimental conditions studied. It does not represent formal analytical validation, cross-platform validation, regulatory validation, or validation of a fully automated high-throughput screening assay. This work defines both the capabilities and constraints of the KIC and provides a methodological foundation for future automated cardiotoxicity screening.
Degree
thesis:*- Name thesis:degree_name
- Master of Science - MSc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Experimental Medicine
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Donaldson-Barrio, Georgia
- Contributors dc:contributor
-
- Laksman, Zachary
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/95287